No takes yet. Share an insight, caveat, or question.
This review summarizes the pharmacological characteristics of levosimendan and its active metabolite OR-1896, focusing on their inotropic, vasodilatory, and cardioprotective effects.
Pathak et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: